Itraconazole for the treatment of histoplasmosis and blastomycosis
- 31 July 1995
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 5 (4), 219-225
- https://doi.org/10.1016/0924-8579(95)00010-6
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Oral Azole Drugs as Systemic Antifungal TherapyNew England Journal of Medicine, 1994
- Blastomycosis in Patients with the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1992
- The effects of food and dose on the oral systemic availability of itraconazole in healthy subjectsEuropean Journal of Clinical Pharmacology, 1989
- BlastomycosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Diagnosis and management of HistoplasmosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndromeAmerican Journal Of Medicine, 1988
- Azole antifungal agents: emphasis on new triazolesAntimicrobial Agents and Chemotherapy, 1988
- Itraconazole: Pharmacologic Studies in Animals and HumansClinical Infectious Diseases, 1987
- Early Experience with Itraconazole in Vitro and in Patients: Pharmacokinetic Studies and Clinical ResultsClinical Infectious Diseases, 1987
- In vitro studies with R 51,211 (itraconazole)Antimicrobial Agents and Chemotherapy, 1984